Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

Clin Sarcoma Res. 2017 Mar 9:7:5. doi: 10.1186/s13569-017-0069-3. eCollection 2017.

Abstract

Background: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases.

Case presentation: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence.

Conclusions: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.

Keywords: Cardiac tumors; Chemotherapy; Leiomyosarcoma; Survival.

Publication types

  • Case Reports